Similarly, an ELSA-Brazil population study documented that non-alcoholic fatty liver disease (NAFLD) was associated with the elevation of the serum advanced glycation end products, as well as an increase in the serum TG, ALT, γ-GTP, and glycated hemoglobin with a decrease in HDL-C [39]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.